Hitachi, Ltd. (“Hitachi”) and MOLCURE Inc. jointly announced that they will launch full-scale co-creation toward providing services based on Hitachi’s Confidential AI Platform, currently under development to accelerate AI-driven drug discovery through open innovation.

For more details, please see the full press release at the link below.

Link: http://molcure.com/wp-content/uploads/2026/04/ENHitachi-MOLCURE_20260416.pdf